27-norcholestane-3,7,12,24,25-pentol: bile alcohol found in urine [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 21252278 |
| CHEBI ID | 166805 |
| SCHEMBL ID | 10659258 |
| MeSH ID | M0095820 |
| Synonym |
|---|
| 27-nor-5beta-cholestane-3alpha,7alpha,12alpha,24xi,25xi-pentol |
| 27-norcholestane-3,7,12,24,25-pentol, (3alpha,5beta,7alpha,12alpha)- |
| 26(or 27)-norcholestane-3,7,12,24,25-pentol |
| 78648-95-0 |
| (3r,5s,7r,8r,9s,10s,12s,13r,14s,17r)-17-[(2r)-5,6-dihydroxyheptan-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthrene-3,7,12-triol |
| 27-nor-5beta-cholestane-3alpha,7alpha,12alpha,24,25-pentol |
| CHEBI:166805 |
| 27-nc-3,7,12,24,25-po |
| 27-norcholestane-3,7,12,24,25-pentol |
| LMST01010213 |
| 27-nor-5b-cholestane-3a,7a,12a,24,25-pentol |
| 27-nor-cholestane-pentol |
| SCHEMBL10659258 |
| 27-nor-pentol |
| DTXSID901262292 |
| (3r,5s,7r,8r,9s,10s,12s,13r,14s,17s)-17-[(2r)-5,6-dihydroxyheptan-2-yl]-10 |
| Class | Description |
|---|---|
| steroid | Any of naturally occurring compounds and synthetic analogues, based on the cyclopenta[a]phenanthrene carbon skeleton, partially or completely hydrogenated; there are usually methyl groups at C-10 and C-13, and often an alkyl group at C-17. By extension, one or more bond scissions, ring expansions and/or ring contractions of the skeleton may have occurred. Natural steroids are derived biogenetically from squalene which is a triterpene. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 8 (80.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (11.73) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 10 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||